#VisualAbstract: Inhibition of CD40L with Frexalimab in Multiple Sclerosis Reduces the Number of New Gadolinium-Enhancing T1 Weighted Lesion
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More
studygraphics
Sham Vs Verum Acupuncture for Combat-Related Posttraumatic Stress Disorder Symptoms
Click here to read this study in JAMA Psychiatry. ©2024 2 Minute Medicine, Inc. All rights...
Read More
#VisualAbstract: Intraoperative wound irrigation with polyhexanide does not prevent surgical site infection after laparotomy
Click here to read this study in JAMA Surgery. ©2024 2 Minute Medicine, Inc. All rights reserved....
Read More
#VisualAbstract: Benralizumab is noninferior to mepolizumab for treatment of eosinophilic granulomatosis with polyangitis
Click here to read this study in The New England Journal of Medicine. ©2024 2 Minute Medicine,...
Read More
#VisualAbstract: Apixaban does not significantly prevent recurrent stroke after cryptogenic stroke in patients with atrial cardiopathy
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read More
#VisualAbstract: Seladelpar for the treatment of primary biliary cholangitis
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read More
#VisualAbstract: Interleukin-23 receptor antagonist improves psoriasis symptoms
1. In this randomized controlled trial, treatment with JNJ-77242113 improved psoriasis symptoms as...
Read More
#VisualAbstract: Electronic nicotine-delivery systems improve smoking cessation
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read More
#VisualAbstract: Stereotactic body radiotherapy enhances survival in patients with non-small cell lung cancer
1. Median progression-free survival was greater in the SBRT group than in the standard-of-care...
Read More
#VisualAbstract: Cefepime-Taniborbactam is superior to meropenem for the treatment of complicated urinary tract infection
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read More
#VisualAbstract: Tenecteplase therapy initiated within 4.5 to 24 hours after stroke symptom onset is non-superior to placebo
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read More
#VisualAbstract: Multidomain interventions from preconception through early childhood improves child neurodevelopment
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read More
#VisualAbstract: Butantan-Dengue Vaccine effective in preventing symptomatic dengue
1. In this randomized controlled trial, the Butantan-Dengue Vaccine (Butantan-DV) was effective in...
Read More
#VisualAbstract: Resmetirom improves outcomes in patients with nonalcoholic steatohepatitis (NASH) compared to placebo
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read More
#VisualAbstract: Atezolizumab in addition to bevacizumab and platinum-based chemotherapy improves survival in metastatic cervical cancer
1. The Atezolizumab group demonstrated significantly greater progression-free and overall survival...
Read More
#VisualAbstract: Iodine povacrylex antisepsis results in fewer site infections than chlorhexidine gluconate after surgical fixation of extremity fractures
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read More
#VisualAbstract: Acoramidis is an efficacious treatment for transthyretin amyloid cardiomyopathy compared to placebo
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read More
#VisualAbstract: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More
#VisualAbstract: Chronic Lymphocytic Leukemia (CLL) therapy with Ibrutinib and Venetoclax guided by measurable residual disease improves progression-free survival
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read More
#VisualAbstract: Ubrogepant is safe and effective for acute treatment of migraine prodrome
1. Absence of moderate or severe headache 24 hours following administration of treatment drug was...
Read More